60 related articles for article (PubMed ID: 23866598)
21. [Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end-stage renal failure: impact of long-term erythropoietin therapy].
Dzgoeva FU; Gatagonova TM; Kadzaeva ZK; Khamitsaeva OV; Kochisova ZKh; Dzueva AT; Bazaeva BG; Bestaeva TL
Ter Arkh; 2013; 85(6):44-50. PubMed ID: 23866598
[TBL] [Abstract][Full Text] [Related]
22. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
Dimković N
Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
[TBL] [Abstract][Full Text] [Related]
23. Epoetin alfa's effect on left ventricular hypertrophy and subsequent mortality.
Jones M; Schenkel B; Just J
Int J Cardiol; 2005 Apr; 100(2):253-65. PubMed ID: 15823633
[TBL] [Abstract][Full Text] [Related]
24. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
25. Pathophysiology of anaemia: focus on the heart and blood vessels.
Metivier F; Marchais SJ; Guerin AP; Pannier B; London GM
Nephrol Dial Transplant; 2000; 15 Suppl 3():14-8. PubMed ID: 11032352
[TBL] [Abstract][Full Text] [Related]
26. Should the hematocrit (hemoglobin) be normalized in Pre-ESRD or dialysis patients? Yes!
Besarab A; Aslam M
Blood Purif; 2001; 19(2):168-74. PubMed ID: 11150804
[No Abstract] [Full Text] [Related]
27. Effect of erythropoietin on cardiovascular diseases.
Sunder-Plassmann G; Hörl WH
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S20-5. PubMed ID: 11576916
[TBL] [Abstract][Full Text] [Related]
28. Left ventricular hypertrophy: why does it happen?
London GM
Nephrol Dial Transplant; 2003 Nov; 18 Suppl 8():viii2-6. PubMed ID: 14607992
[TBL] [Abstract][Full Text] [Related]
29. Pathophysiology of left ventricular hypertrophy in dialysis patients.
London GM; Guerin AP; Marchais SJ
Blood Purif; 1994; 12(4-5):277-83. PubMed ID: 7865187
[TBL] [Abstract][Full Text] [Related]
30. Diastolic dysfunction of the left ventricle in dialysis patients.
Wizemann V; Blank S; Kramer W
Contrib Nephrol; 1994; 106():106-9. PubMed ID: 8174352
[No Abstract] [Full Text] [Related]
31. Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review.
Cerasola G; Nardi E; Palermo A; Mulè G; Cottone S
J Nephrol; 2011; 24(1):1-10. PubMed ID: 20437402
[TBL] [Abstract][Full Text] [Related]
32. What are the short-term and long-term consequences of anaemia in CRF patients?
Mann JF
Nephrol Dial Transplant; 1999; 14 Suppl 2():29-36. PubMed ID: 10334665
[TBL] [Abstract][Full Text] [Related]
33. Impact of regression of left ventricular hypertrophy on cardiac function in hypertension.
Omotoso AB; Dunn FG
Eur Heart J; 1992 Sep; 13 Suppl D():107-10. PubMed ID: 1396853
[TBL] [Abstract][Full Text] [Related]
34. Left ventricular alterations and end-stage renal disease.
London GM
Nephrol Dial Transplant; 2002; 17 Suppl 1():29-36. PubMed ID: 11812909
[TBL] [Abstract][Full Text] [Related]
35. Systolic and diastolic hypertension among patients on hemodialysis: Musings on volume overload, arterial stiffness, and erythropoietin.
Georgianos PI; Agarwal R
Semin Dial; 2019 Nov; 32(6):507-512. PubMed ID: 31463996
[TBL] [Abstract][Full Text] [Related]
36. Cardiac performance and morphology in end-stage renal disease.
Alpert MA
Am J Med Sci; 2003 Apr; 325(4):168-78. PubMed ID: 12695722
[TBL] [Abstract][Full Text] [Related]
37. The beneficial effects of intervention in early renal disease.
Portolés J
Nephrol Dial Transplant; 2001; 16 Suppl 2():12-5. PubMed ID: 11369843
[TBL] [Abstract][Full Text] [Related]
38. [Cardiac anomalies in chronic renal failure].
Guérin A; Marchais S; Pannier B; London G
Presse Med; 2000 Feb; 29(5):274-80. PubMed ID: 10701411
[TBL] [Abstract][Full Text] [Related]
39. [Erythropoietin administration in the predialysis period].
Dimković N
Med Pregl; 2003; 56(11-12):529-35. PubMed ID: 15080045
[TBL] [Abstract][Full Text] [Related]
40. Left ventricular geometry and hypotension in end-stage renal disease: a mechanical perspective.
de Simone G
J Am Soc Nephrol; 2003 Oct; 14(10):2421-7. PubMed ID: 14514719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
